$7.48
6.86%
Nasdaq, Tue, Sep 02 2025
ISIN
US85209E1091
Symbol
SPRB

Spruce Biosciences Inc Stock price

$7.48
-1.52 16.89% 1M
-19.22 71.99% 6M
-24.02 76.25% YTD
-27.37 78.54% 1Y
-140.27 94.94% 3Y
-1,117.52 99.34% 5Y
-1,117.52 99.34% 10Y
-1,117.52 99.34% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
+0.48 6.86%
ISIN
US85209E1091
Symbol
SPRB
Industry

Key metrics

Basic
Market capitalization
$4.3m
Enterprise Value
$-32.7m
Net debt
positive
Cash
$38.8m
Shares outstanding
42.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.9 | 4.2
EV/Sales
negative | negative
EV/FCF
0.6
P/B
0.2
Financial Health
Equity Ratio
63.8%
Return on Equity
-184.0%
ROCE
-187.4%
ROIC
-1,088.2%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$4.9m | $1.0m
EBITDA
$-56.1m | $-88.8m
EBIT
$-56.2m | $-39.5m
Net Income
$-53.0m | $-29.3m
Free Cash Flow
$-56.0m
Growth (TTM | estimate)
Revenue
-51.3% | -79.2%
EBITDA
-8.1% | -58.2%
EBIT
-8.0% | 29.6%
Net Income
-10.7% | 44.8%
Free Cash Flow
-68.2%
Margin (TTM | estimate)
Gross
-
EBITDA
-1,142.4% | -8,704.6%
EBIT
-1,143.4%
Net
-1,079.9% | -2,871.6%
Free Cash Flow
-1,139.6%
More
EPS
$-95.9
FCF per Share
$-1.3
Short interest
1.2%
Employees
9
Rev per Employee
$550.0k
Show more

Is Spruce Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Spruce Biosciences Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Spruce Biosciences Inc forecast:

4x Hold
57%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a Spruce Biosciences Inc forecast:

Hold
57%
Sell
43%

Financial data from Spruce Biosciences Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4.91 4.91
51% 51%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 15 15
16% 16%
298%
- Research and Development Expense 46 46
6% 6%
945%
-56 -56
8% 8%
-1,143%
- Depreciation and Amortization 0.05 0.05
29% 29%
1%
EBIT (Operating Income) EBIT -56 -56
8% 8%
-1,144%
Net Profit -53 -53
11% 11%
-1,080%

In millions USD.

Don't miss a Thing! We will send you all news about Spruce Biosciences Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Spruce Biosciences Inc Stock News

Neutral
Business Wire
20 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the second quarter ended June 30, 2025 and provided corporate updates. “We remain steadfast in our efforts to adv...
Neutral
Business Wire
20 days ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced results from a long-term data integration of tralesinidase alfa enzyme replacement therapy (TA-ERT) clinical program in patients with ...
Neutral
Business Wire
about one month ago
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTCQB: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that it will implement a 1-for-75 reverse stock split of its issued and outstanding shares of common stock (“Reverse Stock Split”), ef...
More Spruce Biosciences Inc News

Company Profile

Spruce Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing novel therapies for rare diseases affecting the endocrine system. The company was founded in 2014 and is headquartered in Daly City, CA.

Head office United States
CEO Javier Szwarcberg
Employees 9
Founded 2014
Website sprucebio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today